The New GLP-1 Pill — No More Injections? - $25 a Month and the Access Revolution

The New GLP-1 Pill — No More Injections? - Swallow the truth with Julia Cartwright

Join host Julia Cartwright as she explores the groundbreaking GLP-1 pill that promises to eliminate injections for weight management. Discover the real science behind this daily tablet alternative, who it's designed for, and whether it can match the effectiveness of traditional shots. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

The New GLP-1 Pill — No More Injections? - Unpack the science changing weight loss forever with Julia Cartwright

Join host Julia Cartwright as she explores the groundbreaking shift from GLP-1 injections to pills for weight loss. Discover how these oral medications work, their effectiveness versus shots, and what this needle-free option means for accessibility and cost. Perfect for anyone curious about weight management's future. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

The New GLP-1 Pill — No More Injections? - Can a Daily Tablet Replace Your Weekly Injection?

Join AI host Julia Cartwright as she compares Foundayo, the FDA-approved daily GLP-1 pill, with injectable Wegovy. We examine clinical trial data showing Foundayo's 12.4% weight loss versus Wegovy's 15-16%, discuss medication adherence challenges, switching protocols, and explore who benefits most from each option in this evolving weight management landscape. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

The New GLP-1 Pill — No More Injections? - $25 a Month and the Access Revolution

Julia Cartwright explores how oral GLP-1 medications transformed obesity treatment access in 2026. Oral Wegovy and Foundayo launched at $25-$149 monthly, eliminating needles and cost barriers that kept 90% of eligible patients untreated. With 170,000 prescriptions in three weeks and home delivery options, the access revolution began reshaping healthcare for millions. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

The New GLP-1 Pill — No More Injections? - Needle-Free at Last, But Who Is This For?

Julia Cartwright explores Foundayo, the FDA-approved daily GLP-1 pill that offers a needle-free alternative for weight management. She examines who truly benefits from this $149/month medication—addressing barriers of cost, needle aversion, and accessibility that keep 90% of eligible patients untreated, while honestly comparing its effectiveness to injectable options. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.